Firalis Molecular Precision acquires Standard BioTools™ Biomark X9 System

Firalis Molecular Precision has expanded its capabilities with the acquisition of the Standard BioTools™ Biomark X9 System. This advanced platform enhances our ability to conduct high-throughput qPCR, genotyping, and NGS library preparation, accelerating biomarker discovery and gene expression monitoring.